The outlook of companies tied to flagship drugs like Viagra presents a challenging investment picture. While the initial boom of copyright, fueled by Viagra's remarkable popularity, generated substantial https://haseebedxr364186.ssnblog.com/39845909/sildenafil-and-its-maker-and-big-pharma-a-dangerous-investment